Medication Adherence Programs (MAP): Reducing Costs Through Better Outcomes

The Adherence Problem

Medication non-adherence — not taking prescribed medications as directed — is one of the most costly and preventable problems in employer health plans. Approximately 50% of patients with chronic conditions do not take their medications as prescribed. The consequences are predictable: uncontrolled diabetes leads to hospitalizations. Uncontrolled hypertension leads to strokes. Uncontrolled asthma leads to ER visits. Each of these events costs the plan far more than the medication that would have prevented it.

Why Members Do Not Adhere

Understanding the barriers to adherence is essential to designing effective interventions. The most common barriers are:

• Cost: High copays and deductibles cause members to skip doses, split pills, or abandon therapy entirely. This is the most addressable barrier through plan design.
• Complexity: Multiple medications with different dosing schedules, refill timing, and administration requirements create confusion and missed doses.
• Side effects: Real or anticipated side effects cause members to stop therapy without consulting their physician.
• Lack of symptoms: Members with asymptomatic conditions (hypertension, high cholesterol) do not feel sick and do not perceive the need for medication.
• Access: Pharmacy inconvenience, prior authorization delays, and mail order friction reduce adherence.
• Health literacy: Members who do not understand why they are taking a medication or what it does are less likely to adhere.

Value-Based Insurance Design (VBID)

Value-based insurance design is a plan design philosophy that aligns cost-sharing with clinical value. High-value services — preventive care, chronic disease medications, evidence-based treatments — have low or zero cost-sharing. Low-value services have higher cost-sharing. The goal is to remove financial barriers to care that prevents disease progression while maintaining cost-sharing signals for discretionary or low-value services.

• Zero cost-sharing for generic chronic disease medications: Eliminating copays for diabetes, hypertension, heart failure, and asthma medications consistently improves adherence and reduces hospitalizations.
• Preferred pharmacy networks: Directing members to pharmacies with better adherence support — 90-day supplies, automatic refills, medication synchronization — improves adherence through convenience.
• Mail order for maintenance medications: 90-day mail order supplies reduce refill gaps and often have lower cost-sharing than retail pharmacy.
• Disease-specific VBID: Waiving cost-sharing for all medications related to a specific condition (e.g., all diabetes medications and supplies) for members with that diagnosis.

Clinical Adherence Programs

Financial incentives alone are not sufficient for all members. Clinical adherence programs provide personalized support to members at high risk of non-adherence.

• Pharmacist-led medication therapy management (MTM): Pharmacists review all medications for a member, identify adherence barriers, simplify regimens, and provide education. MTM is most effective for members on 5 or more medications.
• Medication synchronization: All of a member's maintenance medications are synchronized to refill on the same day each month — reducing pharmacy trips and refill gaps.
• Automated refill programs: Mail order pharmacies automatically refill maintenance medications before the supply runs out — eliminating refill gaps.
• Adherence monitoring: Digital tools that track refill patterns and alert care managers when a member has not refilled a critical medication.
• Chronic disease management programs: Integrated programs that combine medication management with lifestyle coaching, remote monitoring, and clinical support for members with diabetes, hypertension, or heart failure.

Measuring Adherence Program Effectiveness

Adherence programs must be measured to demonstrate ROI and guide program improvement. The standard metric for medication adherence is the Proportion of Days Covered (PDC) — the percentage of days in a measurement period for which the member had medication available.

• PDC ≥ 80% is the standard threshold for adherence for most chronic conditions.
• Baseline PDC for common chronic conditions in employer populations is typically 50 to 70% — well below the adherence threshold.
• Track PDC by condition and by intervention type to identify which programs are most effective.
• Correlate adherence improvements with downstream medical cost changes — hospitalizations, ER visits, and specialist costs for the targeted conditions.
• Report adherence metrics to leadership annually alongside the financial ROI calculation.